Akanda corp. provides update on scheduling policy in us aims to be among first international movers in us pending approval

London, united kingdom--(newsfile corp. - february 2, 2024) - akanda corp. (nasdaq: akan) ("akanda" or the "company"), an international medical cannabis company, today announces it is actively following the developments in federal us policy to reschedule and/or deschedule cannabis under the controlled substances act ("csa"). the company believes rescheduling may reinvigorate capital markets and could lead to changes in nasdaq and nyse rules on listing plant-touching u.s. companies.
AKAN Ratings Summary
AKAN Quant Ranking